VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine)
offering product urn:matchory:offering:01m772jz49eqv8w8ytqkt78frm
Offered by Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity). Relation: not stated. Commodity: 51201621 Tetanus vaccine (commodity).
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Name as stated name | VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) | products products 2 | VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine)https://www.merck.com/products/ |
2026-11-12 | current |
| Name as stated name | VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) | extraction extract 3 | VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine)https://www.merck.com/products/ |
2026-11-12 | current |
| UNSPSC classification unspsc | 51201621 (8 candidates considered) (0.88) | classification unspsc 3 | 2026-11-12 | current |